Jim Simons Neoleukin Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.68 - $0.91 $15,374 - $20,575	22,610 Added 2.47%	937,223 $778,000
Q1 2023 May 12, 2023	SELL	$0.5 - $0.72 $139,417 - $200,760	-278,834 Reduced 23.36%	914,613 $640,000
Q4 2022 Feb 13, 2023	SELL	$0.4 - $0.55 $99,448 - $136,741	-248,620 Reduced 17.24%	1,193,447 $607,000
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $118,813 - $229,016	-172,193 Reduced 10.67%	1,442,067 $923,000
Q2 2022 Aug 12, 2022	BUY	$0.92 - $2.25 $317,667 - $776,904	345,291 Added 27.21%	1,614,260 $1.66 Million
Q1 2022 May 13, 2022	BUY	$1.72 - $5.23 $731,614 - $2.22 Million	425,357 Added 50.42%	1,268,969 $2.39 Million
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.75 $403,248 - $672,080	86,720 Added 11.46%	843,612 $4.07 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $9.66 $1.09 Million - $1.75 Million	180,900 Added 31.41%	756,892 $5.47 Million
Q2 2021 Aug 13, 2021	SELL	$9.23 - $13.12 $387,152 - $550,318	-41,945 Reduced 6.79%	575,992 $5.32 Million
Q1 2021 May 13, 2021	SELL	$11.26 - $15.78 $1.63 Million - $2.28 Million	-144,755 Reduced 18.98%	617,937 $7.61 Million
Q4 2020 Feb 10, 2021	SELL	$10.17 - $14.56 $757,105 - $1.08 Million	-74,445 Reduced 8.89%	762,692 $10.8 Million
Q3 2020 Nov 13, 2020	SELL	$9.68 - $17.01 $1.97 Million - $3.46 Million	-203,155 Reduced 19.53%	837,137 $10 Million
Q2 2020 Aug 13, 2020	BUY	$9.95 - $17.05 $1.92 Million - $3.29 Million	193,200 Added 22.81%	1,040,292 $17.3 Million
Q1 2020 May 14, 2020	BUY	$6.12 - $13.64 $781,560 - $1.74 Million	127,706 Added 17.75%	847,092 $9.64 Million
Q4 2019 Feb 13, 2020	SELL	$2.65 - $12.72 $128,405 - $616,347	-48,455 Reduced 6.31%	719,386 $8.86 Million
Q3 2019 Nov 13, 2019	BUY	$2.33 - $3.76 $1.79 Million - $2.89 Million	767,841 New	767,841 $2.19 Million

Others Institutions Holding NLTX

# of Institutions

Shares Held

199K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

199K
Shares

$0
0.18% of portfolio

View Full List

About Neoleukin Therapeutics, Inc.

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

More about NLTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account